Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
24.0%
% of FTXH's 51 holdings also in MEDX
40.0%
% of MEDX's 30 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 7.0% | 8.8% | 7.0% |
|
BRISTOL-MYERS SQUIBB CO | 7.0% | 5.8% | 5.8% |
|
JOHNSON & JOHNSON | 8.1% | 5.3% | 5.3% |
|
ELI LILLY & CO | 3.9% | 18.6% | 3.9% |
|
AMGEN INC | 3.8% | 6.2% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to MEDX
|
GILEAD SCIENCES INC | 3.9% |
|
UNITED THERAPEUTICS CORP | 3.8% |
|
ZOETIS INC | 3.8% |
|
MERCK & CO. INC. | 3.7% |
|
PFIZER INC | 3.3% |
|
VIATRIS, INC. | 3.3% |
 |
JAZZ PHARMACEUTICALS PLC | 3.0% |
|
JOHNSON & JOHNSON | 2.8% |
|
ORGANON & CO. | 2.3% |
|
EXELIXIS INC | 2.1% |
FTXH Underweight Relative to MEDX
|
ELI LILLY & CO | -14.8% |
 |
NOVARTIS AG-ADR | -7.0% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
|
ALNYLAM PHARMACEUTICALS INC | -3.9% |
|
ALKERMES PLC | -3.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.6% |
|
AMGEN INC | -2.4% |
|
IONIS PHARMACEUTICALS, INC. | -2.3% |
|
ABBVIE INC | -1.8% |